Temperature-Sensitive Nano-Carriers via Photo-Crosslinking
Solution Overview
Problem
Conventional methods for preparing nanoparticles for drug delivery face challenges such as the use of organic solvents, which are cytotoxic and increase preparation costs, limited solubility in supercritical fluids, and instability of protein drugs due to crosslinking agents, leading to complications in achieving stable and efficient drug encapsulation.
Innovation Solution
A simple single-phase process involving the crosslinking of a water-soluble biocompatible polymer with photo-crosslinkable functional groups under appropriate conditions to create temperature-sensitive nano-carriers, which allows for reversible size changes with temperature and spontaneous encapsulation of therapeutic agents without the need for organic solvents or high-speed homogenization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If organic solvents are used for dissolving PLGA to prepare microspheres, then the polymer can be effectively dissolved and processed, but cytotoxicity increases and preparation cost increases
Solution Approach 1:
The invention extracts and removes organic solvents from the nanoparticle preparation process entirely. Instead, it uses a water-based system where PLGA is dissolved in water-soluble organic solvents (like acetone or ethanol) that are subsequently evaporated, eliminating cytotoxicity while maintaining manufacturing feasibility
Solution Approach 2:
The invention changes the solvent parameters from highly hydrophobic organic solvents to water-soluble organic solvents with lower toxicity. This parameter change allows the polymer to be dissolved and processed effectively while reducing cytotoxicity and preparation cost
2Stability of the object's composition
If crosslinking agents are used to manufacture nanoparticles, then nanoparticle structure is formed, but protein drug stability is seriously damaged
Solution Approach 1:
The invention extracts and removes crosslinking agents from the nanoparticle preparation process. Instead of using chemical crosslinking that damages proteins, it relies on physical entrapment of proteins within the PLGA matrix during emulsion formation, preserving protein drug stability while maintaining nanoparticle structure
Solution Approach 2:
The invention introduces an intermediary approach where proteins are protected from direct exposure to harsh chemicals by being entrapped within the forming nanoparticle matrix. The PLGA polymer acts as a protective barrier during the water-based preparation process, preventing protein denaturation
3Quantity of substance
If conventional emulsion evaporation method is used to prepare nanoparticles, then drug encapsulation is achieved, but the process becomes complicated and organic solvent problems arise
Solution Approach 1:
The invention merges the dissolution, emulsion formation, and nanoparticle generation steps into a single simplified water-based process. By using water-soluble organic solvents that can be easily evaporated, it combines multiple conventional steps into one straightforward procedure, reducing complexity while maintaining drug encapsulation efficiency
Solution Approach 2:
The invention replaces complex mechanical homogenization and high-speed processing with a simplified emulsion evaporation approach. The use of water-soluble solvents allows nanoparticles to form and stabilize more easily, reducing the need for complex mechanical intervention while achieving effective drug encapsulation
4Object-affected harmful factors
If supercritical fluids are used for nanoparticle preparation, then nontoxic solvent benefit is achieved, but polymer solubility is limited
Solution Approach 1:
The invention changes the solvent parameters from supercritical fluids to water-soluble organic solvents (acetone, ethanol) that offer both nontoxicity and superior polymer solubility. This parameter change maintains the safety benefit while dramatically improving adaptability to PLGA and other hydrophobic polymers
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach ensures the stability and sustained release of therapeutic agents by avoiding denaturation and aggregation, overcoming the limitations of previous methods, and achieving high encapsulation efficiency and cost-effectiveness.
Implementation Method 1
crosslinking a water-soluble biocompatible polymer having a photo-crosslinkable functional group
Implementation Method 2
the average diameter of the nano-carriers changes depending on temperature
Data Source
AI summary
The present invention relates to a process of preparing a biocompatible temperature-sensitive nano-carrier, which comprises the steps of (a) preparing a polymer dispersion comprising a water-soluble biocompatible polymer with photo-crosslinkable functional group(s), (b) preparing a polymer-initiator solution by adding an initiator to the polymer dispersion, and (c) preparing the nano-carrier by irradiating light onto the polymer-initiator solution, wherein the average diameter of the nano-carrier changes depending on temperature, and also relates to a temperature-sensitive nano-carrier. Nano-carriers of the present invention are temperature-sensitive, and their average diameter and pore size reversibly change in response to temperature change. In an embodiment of the present invention, nano-carriers can be prepared via a one-pot single-phase synthesis. A process of the present invention overcomes the conventional problems such as the use of organic solvent, complicated preparation steps, a relatively high manufacture cost and a low loading efficiency. Moreover, a process of the present invention can ensure the stability of drugs without necessitating high-speed homogenization or ultrasonification generally carried out in the conventional process.



